Mural Oncology
$0
11
+$0+0% Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
31MarExpected
Expected EPS
-0.37
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-128.51MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MURA V. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.
Show more...
CEO
Ms. Caroline J. Loew Ph.D.
Employees
116
Country
Ireland
Listings
0 Comments
Share your thoughts
FAQ
What is Mural Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mural Oncology stocks are traded under the ticker MURA V.
What is Mural Oncology revenue for the last year?▼
Mural Oncology revenue for the last year amounts to 0 USD.
What is Mural Oncology net income for the last year?▼
MURA V net income for the last year is -128.51M USD.
How many employees does Mural Oncology have?▼
As of April 29, 2026, the company has 116 employees.
In which sector is Mural Oncology located?▼
Mural Oncology operates in the Health & Wellness sector.
When did Mural Oncology complete a stock split?▼
Mural Oncology has not had any recent stock splits.
Where is Mural Oncology headquartered?▼
Mural Oncology is headquartered in Dublin, Ireland.